Mark A. Greenberg

The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings

Hiltrud S. Mueller, A. R. DYER, Mark A. Greenberg · 1985 · 3.6K citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +7

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

James Slater, Robert Brown, Tracy A Antonelli et al. · Journal of the American College of Cardiology · 2000 · 195 citations

Cardiogenic Shock, Cardiovascular Disease, Myocardial Infarction +6

Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure

Richard Grose, Janet Strain, Mark A. Greenberg et al. · Journal of the American College of Cardiology · 1986 · 158 citations

Cardiovascular Toxicity, Heart Failure, Cardiogenic Shock +10

Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries

Mark A. Greenberg, Richard Grose, N Neuburger et al. · Journal of the American College of Cardiology · 1987 · 132 citations

Normal Coronary Arteries, Cardiovascular Disease, Coronary Artery Disease +10

Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization

Richard Charney, Matthew E. Schwinger, Jenny Chun et al. · American Heart Journal · 1994 · 123 citations

Cardiovascular Disease, Myocardial Infarction, Dobutamine Echocardiography +8